These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22842111)

  • 1. A case of acquired dysfibrinogenemia in multiple myeloma treated with therapeutic plasma exchange.
    Post GR; James L; Alapat D; Guillory V; Cottler-Fox M; Nakagawa M
    Transfus Apher Sci; 2013 Feb; 48(1):35-8. PubMed ID: 22842111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired dysfibrinogenemia secondary to multiple myeloma.
    Kotlín R; Sobotková A; Riedel T; Salaj P; Suttnar J; Reicheltová Z; Májek P; Khaznadar T; Dyr JE
    Acta Haematol; 2008; 120(2):75-81. PubMed ID: 18841003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired dysfibrinogenemia secondary to mithramycin toxicity.
    Ashby MA; Lazarchick J
    Am J Med Sci; 1986 Jul; 292(1):53-5. PubMed ID: 2940861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increased thrombin time in a patient with multiple myeloma].
    Bohler A; Redondo M; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):491-4. PubMed ID: 10517116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired hypofibrinogenemia in a patient with multiple myeloma.
    Inano S; Oku Y; Aiba A; Kawasaki N; Okamoto Y; Yuhi N; Shibata S; Takiuchi Y; Tabata S; Kitano T
    Int J Hematol; 2021 Sep; 114(3):395-400. PubMed ID: 34057670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma exchange after hematopoietic stem cell transplantation in multiple myeloma to reduce renal insufficiency.
    Sullivan K; Jagannath S; Mazumder A; Vesole DH
    Bone Marrow Transplant; 2008 Dec; 42(11):767. PubMed ID: 18695665
    [No Abstract]   [Full Text] [Related]  

  • 7. Improved peripheral blood stem cell collection following plasma exchange in a patient with elevated viscosity and coagulopathy.
    Alex J; Erickson YO; Schlueter AJ
    J Clin Apher; 2007; 22(6):339-41. PubMed ID: 18095304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma presenting with acquired factor VIII inhibitor.
    Sari I; Erkurt MA; Ifran A; Kaptan K; Beyan C
    Int J Hematol; 2009 Sep; 90(2):166-169. PubMed ID: 19551464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding diathesis in multiple myeloma.
    Saif MW; Allegra CJ; Greenberg B
    J Hematother Stem Cell Res; 2001 Oct; 10(5):657-60. PubMed ID: 11672511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of therapeutic plasma exchange in a patient with coagulation inhibitors (acquired haemophilia A) - A case report.
    Kumari S; Tripathi PP; Sharma RR; Hans R; Lamba DS; Khadwal A; Singh C
    Transfus Apher Sci; 2020 Aug; 59(4):102809. PubMed ID: 32527615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-like anticoagulant associated with multiple myeloma and neutralized with protamine sulfate.
    Torjemane L; Guermazi S; Ladeb S; Ben Romdhane N; Lakhal A; Abdelkefi A; Ben Othman T; Ben Abdelhadhim A
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):279-81. PubMed ID: 17413766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-like anticoagulant associated with plasma cell myeloma.
    Chapman GS; George CB; Danley DL
    Am J Clin Pathol; 1985 Jun; 83(6):764-6. PubMed ID: 3923825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma exchange in the therapy of multiple myeloma].
    Ikeda Y; Nakase K; Yamaguchi T; Itoh S; Tsuji K
    Rinsho Ketsueki; 1987 Oct; 28(10):1855-9. PubMed ID: 3452649
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of fibrin monomer polymerisation by myeloma immunoglobulin.
    O'Kane MJ; Wisdom GB; Desai ZR; Archbold GP
    J Clin Pathol; 1994 Mar; 47(3):266-8. PubMed ID: 8163700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfibrinogenemia in a patient undergoing artificial abortion after misdiagnosis and review of the literature.
    Yan J; Deng D; Luo M; Cheng P; Chi B; Yuan Y; Liao L; Lin F
    Clin Chim Acta; 2015 Jul; 447():86-9. PubMed ID: 26057201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma exchange therapy of myeloma].
    Mizuno M; Kawashima S
    Nihon Rinsho; 1992 Jan; 50 Suppl():304-11. PubMed ID: 1578699
    [No Abstract]   [Full Text] [Related]  

  • 17. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H; Galanakis D
    J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of membrane plasma exchange on the hemostatic system and on thyroid hormones in critically ill patients.
    Krämer BK; Ickrath O; Keppler G; Ress KM; Risler T
    Int J Artif Organs; 1987 May; 10(3):199-204. PubMed ID: 3610373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of replacement fluids on coagulation system used for therapeutic plasma exchange.
    Tek I; Arslan O; Arat M; Ozcan M; Akdağ B; Ilhan O
    Transfus Apher Sci; 2003 Feb; 28(1):3-7. PubMed ID: 12620262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case of multiple myeloma associated with hyperviscosity syndrome successfully treated with plasma exchange using a cellulose acetate hollow fiber system].
    Nakazawa H; Kasuga Y; Iga R; Komukai M; Maeda S; Fujihiro S; Katoh H; Watanabe K; Toyama K
    Rinsho Ketsueki; 1982 Apr; 23(4):506-10. PubMed ID: 7131792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.